Forced Expiratory Volume
"Forced Expiratory Volume" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity.
Descriptor ID |
D005541
|
MeSH Number(s) |
E01.370.386.700.660.230 G09.772.650.430
|
Concept/Terms |
Forced Expiratory Volume- Forced Expiratory Volume
- Expiratory Volume, Forced
- Expiratory Volumes, Forced
- Forced Expiratory Volumes
- Volume, Forced Expiratory
- Volumes, Forced Expiratory
- FEVt
- Vital Capacity, Timed
- Forced Vital Capacity, Timed
- Timed Vital Capacity
- Capacities, Timed Vital
- Capacity, Timed Vital
- Timed Vital Capacities
- Vital Capacities, Timed
|
Below are MeSH descriptors whose meaning is more general than "Forced Expiratory Volume".
Below are MeSH descriptors whose meaning is more specific than "Forced Expiratory Volume".
This graph shows the total number of publications written about "Forced Expiratory Volume" by people in UAMS Profiles by year, and whether "Forced Expiratory Volume" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 0 | 1 | 1 | 2022 | 0 | 1 | 1 | 2021 | 0 | 1 | 1 | 2020 | 1 | 1 | 2 | 2019 | 0 | 1 | 1 | 2018 | 0 | 1 | 1 | 2016 | 0 | 3 | 3 | 2015 | 0 | 2 | 2 | 2014 | 1 | 0 | 1 | 2013 | 0 | 2 | 2 | 2012 | 0 | 1 | 1 | 2011 | 0 | 2 | 2 | 2009 | 1 | 2 | 3 | 2004 | 0 | 2 | 2 | 2003 | 0 | 2 | 2 | 2002 | 0 | 1 | 1 | 1999 | 0 | 1 | 1 | 1998 | 1 | 1 | 2 | 1994 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Forced Expiratory Volume" by people in Profiles over the past ten years.
-
Locke ER, Thomas RM, Simpson TL, Fortney JC, Battaglia C, Trivedi RB, Gylys-Colwell J, Swenson ER, Edelman JD, Fan VS. Cognitive and Emotional Responses to Chronic Obstructive Pulmonary Disease Exacerbations and Patterns of Care Seeking. Ann Am Thorac Soc. 2024 Apr; 21(4):559-567.
-
Ramsey NB, Apter AJ, Israel E, Louisias MM, Noroski LM, Nyenhuis SM, Ogbogu PU, Perry TT, Wang J, Davis CM. Reply to "How to deconstruct 'race' and spirometry". J Allergy Clin Immunol Pract. 2022 09; 10(9):2489-2491.
-
Attaway AH, Welch N, Yadav R, Bellar A, Hatipoglu U, Meli Y, Engelen MPKJ, Zein J, Dasarathy S. Quantitative Computed Tomography Assessment of Pectoralis and Erector Spinae Muscle Area and Disease Severity in Chronic Obstructive Pulmonary Disease Referred for Lung Volume Reduction. COPD. 2021 04; 18(2):191-200.
-
Berlinski A. Implementation of pediatric home spirometry: potential height bias. J Cyst Fibros. 2021 07; 20(4):719-720.
-
Secunda KE, Guimbellot JS, Jovanovic B, Heltshe SL, Sagel SD, Rowe SM, Jain M. Females with Cystic Fibrosis Demonstrate a Differential Response Profile to Ivacaftor Compared with Males. Am J Respir Crit Care Med. 2020 04 15; 201(8):996-998.
-
Sherman AC, Simonton-Atchley S, Campbell D, Reddy RM, O'Brien CE, Guinee B, Wagner LD, Anderson PJ. Persistent Adherence to Airway Clearance Therapy in Adults With Cystic Fibrosis. Respir Care. 2019 Jul; 64(7):778-785.
-
Guimbellot J, Solomon GM, Baines A, Heltshe SL, VanDalfsen J, Joseloff E, Sagel SD, Rowe SM. Effectiveness of ivacaftor in cystic fibrosis patients with non-G551D gating mutations. J Cyst Fibros. 2019 01; 18(1):102-109.
-
Jonker R, Deutz NE, Erbland ML, Anderson PJ, Engelen MP. Effectiveness of essential amino acid supplementation in stimulating whole body net protein anabolism is comparable between COPD patients and healthy older adults. Metabolism. 2017 Apr; 69:120-129.
-
Dickinson KJ, Taswell JB, Allen MS, Blackmon SH, Nichols FC, Shen R, Wigle DA, Cassivi SD. Unplanned Readmission After Lung Resection: Complete Follow-Up in a 1-Year Cohort With Identification of Associated Risk Factors. Ann Thorac Surg. 2017 Apr; 103(4):1084-1091.
-
Jonker R, Deutz NE, Erbland ML, Anderson PJ, Engelen MP. Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease. Am J Clin Nutr. 2016 06; 103(6):1458-64.
-
Stolarz AJ, Farris RA, Wiley CA, O'Brien CE, Price ET. Fenofibrate Attenuates Neutrophilic Inflammation in Airway Epithelia: Potential Drug Repurposing for Cystic Fibrosis. Clin Transl Sci. 2015 Dec; 8(6):696-701.
-
Machogu E, Cao Y, Miller T, Simpson P, Levy H, Quintero D, Goday PS. Comparison of WHO and CDC growth charts in predicting pulmonary outcomes in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2015 Mar; 60(3):378-83.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|